Log in

NASDAQ:ONTXOnconova Therapeutics Earnings Date, Estimates & History

-0.02 (-4.59 %)
(As of 05/22/2020 04:00 PM ET)
Today's Range
Now: $0.42
50-Day Range
MA: $0.32
52-Week Range
Now: $0.42
Volume9.63 million shs
Average Volume8.91 million shs
Market Capitalization$70.12 million
P/E RatioN/A
Dividend YieldN/A


Onconova Therapeutics (NASDAQ:ONTX) Earnings Information

Onconova Therapeutics last issued its quarterly earnings data on May 14th, 2020. The biopharmaceutical company reported ($0.03) EPS for the quarter, beating analysts' consensus estimates of ($0.04) by $0.01. The firm earned $0.05 million during the quarter, compared to analyst estimates of $0.10 million. Onconova Therapeutics has generated ($1.49) earnings per share over the last year. Onconova Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 12th, 2020 based off prior year's report dates.

Onconova Therapeutics Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Onconova Therapeutics (NASDAQ:ONTX) Earnings Estimates

Current Year EPS Consensus Estimate: $-0.1 EPS
Next Year EPS Consensus Estimate: $-0.13 EPS

Onconova Therapeutics (NASDAQ ONTX) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
5/14/20203/31/2020($0.04)($0.03)($0.03)$0.10 million$0.05 millionTranscript
11/12/2019Q3 2019($0.76)($0.75)($0.75)$0.31 million$0.06 millionN/A
8/14/2019Q2 2019($0.98)($0.60)($0.60)$0.25 million$2.02 millionN/A
5/14/20193/31/2019($1.11)($1.29)($1.29)$0.08 million$0.07 millionN/A
3/26/201912/31/2018($1.09)($0.85)($0.85)$0.22 million$0.06 millionTranscript
11/13/2018Q3($0.78)($0.94)($0.94)$1.87 million$0.12 millionN/A
8/14/2018Q2 2018($1.20)($1.05)($0.09)$0.52 million$0.49 millionN/A
5/15/2018Q1 2018($5.85)($5.10)($0.34)$0.48 million$0.56 millionTranscript
3/8/2018Q4 2017($10.35)($8.85)($0.59)$0.31 million$0.14 millionTranscript
11/9/2017Q3 2017($10.95)($10.65)($0.71)$0.29 million$0.11 millionN/A
8/14/2017Q2 2017($10.80)($4.35)($0.29)$0.25 million$0.32 millionN/A
5/15/2017Q1 2017($14.40)($18.45)($1.23)$0.21 millionN/A
3/27/2017Q4 2016($8.10)($0.54)$0.17 millionN/A
11/14/2016Q3 2016($4.33)($4.33)$1.60 million$1.70 millionN/A
8/15/2016Q2 2016($29.25)($29.25)$2.25 millionN/A
5/11/2016Q1 2016($28.36)($40.30)($40.30)$1.34 million$1.47 millionN/A
3/28/2016Q4 2015$26.87$26.87$9.60 millionN/A
11/11/2015Q3 2015($43.28)($38.81)($38.81)$0.11 million$1.62 millionN/A
8/13/2015Q2 2015($83.58)($61.19)($61.19)$0.11 million$0.12 millionN/A
5/14/2015Q1 2015($94.03)($85.07)($85.07)$0.11 million$0.11 millionN/A
3/26/2015Q4 2014($105.97)($92.54)($92.54)$0.11 millionN/A
11/13/2014Q3 2014($116.42)($102.99)($102.99)$0.11 millionTranscript
8/13/2014Q2 2014($132.84)($114.93)($114.93)$0.56 million$0.13 millionN/A
5/12/2014Q1 2014($116.42)($129.85)($129.85)$1.32 million$0.45 millionListen
3/10/2014Q4 2013($146.27)($101.49)($101.49)$1.07 million$1.93 millionN/A
11/12/2013Q3 2013($116.42)($200.00)($200.00)$1.07 million$1.12 millionListen
9/6/2013Q2 2013($116.42)($777.61)($777.61)$0.22 million$0.59 millionN/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 5/24/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.